Abstract
No public abstract is available from the verified source records.
Ying-Chuan Wang, Ya-Hsin Yao, Sunny Jui-Shan Lin, Chun-Hsiang Chiu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The development and application of NRICM101 and NRICM102 for the treatment of COVID-19
10.1016/j.jfma.2023.04.015 · 2023
Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19
10.1186/s12929-023-00923-5 · 2023
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study
10.1016/j.biopha.2020.111037 · 2021
Pharmacological mechanism of NRICM101 for COVID-19 treatments by combined network pharmacology and pharmacodynamics
10.3390/ijms232315385 · 2022
Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis
10.1016/j.phrs.2022.106424 · 2022
SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19
10.1007/s15010-023-02142-4 · 2024
The role of IL-6 in coronavirus, especially in COVID-19
2022
Unveiling COVID-19 secrets: harnessing cytokines as powerful biomarkers for diagnosis and predicting severity
10.2147/jir.s439217 · 2023
Unresolved referenced work
2022
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
10.1016/s0140-6736(20)30183-5 · 2020
Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury
10.1093/nsr/nwaa037 · 2020
NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model
10.3389/fphar.2023.1125414 · 2023
Chinese herbal prescriptions for COVID-19 management: special reference to Taiwan Chingguan Yihau (NRICM101)
10.3389/fphar.2022.928106 · 2022
Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients: a propensity score–matched analysis
2023
The pharmacological efficacy of baicalin in inflammatory diseases
10.3390/ijms24119317 · 2023
Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by upregulating IFN-γ and inhibiting the TGF-β1/Smad pathway
10.1016/j.intimp.2012.03.011 · 2012
Isatis tinctoria L. derived petroleum ether extract mediates anti-inflammatory effects via inhibition of interleukin-6, interleukin-33 and mast cell degranulation
10.2340/00015555-3476 · 2020
Trichosanthes kirilowii ethanol extract and cucurbitacin D inhibit cell growth and induce apoptosis through inhibition of STAT3 activity in breast cancer cells
10.1155/2013/975350 · 2013
Pharmacology, toxicity, bioavailability, and formulation of magnolol: an update
2021
The phenolic fraction of Mentha haplocalyx and its constituent linarin ameliorate inflammatory response through inactivation of NF-κB and MAPKs in lipopolysaccharide-induced RAW264.7 cells
10.3390/molecules22050811 · 2017
Suppression of tumour necrosis factor-α by Schizonepeta tenuifolia water extract via inhibition of IκBα degradation and Jun N-terminal kinase/stress-activated protein kinase activation
10.1111/j.2042-7158.2010.01126.x · 2010
Anti-inflammatory activity of mulberry leaf flavonoids in vitro and in vivo
10.3390/ijms23147694 · 2022
Anti-inflammatory and antiosteoarthritis effects of Saposhnikovia divaricata ethanol extract: in vitro and in vivo studies
10.1155/2016/1984238 · 2016
Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner
10.1189/jlb.0112038 · 2012
No additional external references are available.